795 impact of single fluid-filled intragastric balloon on metabolic parameters and nonalcoholic steatohepatitis: a prospective paired endoscopic ultrasound guided core liver biopsy at the time of balloon placement and removal

Nonalcoholic Steatohepatitis (NASH) with early fibrosis is serious condition that afflicts a significant portion of patients with obesity with the potential to progress to cirrhosis. The degree of weight loss is independently associated with improvements in all NASH-related histologic parameters when a threshold of ≥ 10% of total body weight (%TBWL) is achieved. Only the minority of patients can reach this threshold with non-surgical obesity interventions. The Orbera Intragastric Balloon (IGB) (Apollo Endosurgery, Austin, TX) is a safe endoscopic bariatric device that achieves ≥ 10% TBWL in the majority of patients .

Source: Gastrointestinal Endoscopy - May 30, 2018 Category: Gastroenterology Authors: Fateh Bazerbachi, Eric J. Vargas, Taofic Mounajjed, Sudhakar K. Venkatesh, Kymberly D. Watt, John D. Port, Rita Basu, Monika Rizk, Andres Acosta, Ibrahim Hanouneh, Naveen Gara, Meera Shah, Manpreet Mundi, Matthew Clark, Karen Grothe, Andrew C. Storm, Mark Tags: Oral abstract Source Type: research